Tuesday, October 10, 2006

2010: kinases $58B annually (Pharmaprojects)

According to a new report, the kinase-targeted drug market is set to grow from $12.7 bn (€10bn) in 2005 to $58.6bn in 2010. Cancer (mainly solid tumours) is expected to remain the dominant application throughout the forecast period.

No comments: